Application of a new statistical approach to evaluate a clinical trial with panic disorder patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue 1, 1999, Pages 21-27

  Bandelow, B ^a,b   Brunner, E ^a   Beinroth, D ^a   Pralle, L ^a   Broocks, A ^a   Hajak, G ^a   Ruther E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Department of Medical Statistics University of Göttingen ^*  (Germany)

Author keywords

Agoraphobia; Imipramine; Panic disorder; Rank test; Self exposure

Indexed keywords

IMIPRAMINE; PROMETHAZINE;

AGORAPHOBIA; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DROWSINESS; HAMILTON SCALE; HUMAN; HYPOTENSION; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; RATING SCALE; STATISTICAL ANALYSIS; XEROSTOMIA;

EID: 0032765732     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004060050061     Document Type: Article

References (21)

1. Akritas MG, Arnold SF (1994) Fully non-parametric hypothesis for factorial designs. I. Multivariate repeated measures design. J Am Statist Assoc 89: 336-343
2. Akritas MG, Brunner E (1996) Rank tests for patterned alternatives in factorial designs with interactions. In: Brunner E, Denker M (eds.) Research developments in probability and statistics. Festschrift in honor of Madan L. Puri on the occasion of the 65th birthday. VSP International Science Publishers, Utrecht, pp 277-288
3. Akritas MG, Brunner E (1997) A unified approach to rank tests in mixed models. J Statist Planning Inference 61:249-277
4. Al-Kubaisy T, Marks I, Logsdail S et al. (1992) Role of exposure homework in phobia education: a controlled study. Behav Ther 23:599-621
5. Bandelow B (1995) Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10: 73-81
6. Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, Hillmer-Vogel U, Rüther E (1998) Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. American Journal of Psychiatry 155:603-609
7. Brunner E, Denker M (1994) Rank statistics under dependent observations and applications to factorial designs. J Statist Planning Inference 42:353-378
8. Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C (1985) The Mobility Inventory for Agoraphobia. Behav Res Ther 23:35-44
9. CNCPS (1992) Cross-national collaborative panic study. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 160: 191-202
10. Coryell W, Noyes R (1988) Placebo response in panic disorder. Am J Psychiatry 145: 1138-1140
11. Friedman M (1937) The use of ranks to avoid the assumption of normality implicit in the analysis of variance. J Am Statist Assoc 32:675-699
12. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
13. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statistics 6:65-70
14. Klein D (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacology 5:397-408
15. Marks IM, Matthews AM (1979) Brief standard self-rating for phobic patients. Behav Res Ther 17:263-267
16. Munzel U, Bandelow B (1998) The use of parametric vs non-parametric tests in the statistical evaluation of rating scales. Pharmacopsychiatry 31:222-224
17. NIMH (1976) National Institute of Mental Health. 028 CGl. Clinical Global Impressions. In: Guy E (ed) ECDEU assessment manual for psychopharmacology, revised edn. NIMH, Rockville. Maryland, pp 217-222
18. Page EB (1963) Ordered hypothesis for multiple treatments: a significance test for linear ranks. J Am Statist Ass 58:216-230
19. Rosenthal R (1984) Meta-analytic procedures for social research. Applied Social Research Methods Series, vol 6. Sage, Beverly Hills
20. Spielberger CD, Gorsuch RL, Lushene RE (1979) State-trait anxiety inventory ("Self-evaluation Questionnaire"). Consulting Psychologists Press, Palo Alto, Calif.
21. Wittchen HU, Zaudig M, Schramm E et al. (1990) Strukturiertes Klinisches Interview für DSM-III-R. Beltz, Weinheim, Basel